Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

25(OH)D levels in trained versus sedentary university students at 64° north.

Jerome SP, Sticka KD, Schnurr TM, Mangum SJ, Reynolds AJ, Dunlap KL.

Int J Circumpolar Health. 2017;76(1):1314414. doi: 10.1080/22423982.2017.1314414.

2.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

3.

Pinpointing the vesper bat transposon revolution using the Miniopterus natalensis genome.

Platt RN 2nd, Mangum SF, Ray DA.

Mob DNA. 2016 Jul 22;7:12. doi: 10.1186/s13100-016-0071-y. eCollection 2016.

4.

Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.

Leonardi S, Lopes RD, Steg PG, Abnousi F, Menozzi A, Prats J, Mangum S, Wilson M, Todd M, Stone GW, Gibson CM, Hamm CW, Price MJ, White HD, Harrington RA, Bhatt DL, Mahaffey KW.

Eur Heart J Acute Cardiovasc Care. 2016 Aug 2. pii: 2048872616661692. [Epub ahead of print]

PMID:
27485140
5.

Hemophagocytic Lymphohistiocytosis and Progressive Disseminated Histoplasmosis.

Ferguson-Paul K, Mangum S, Porter A, Leventaki V, Campbell P, Wolf J.

Emerg Infect Dis. 2016 Jun;22(6):1119-21. doi: 10.3201/eid2206.151682. No abstract available.

6.

Contrasting Patterns of Evolutionary Diversification in the Olfactory Repertoires of Reptile and Bird Genomes.

Vandewege MW, Mangum SF, Gabaldón T, Castoe TA, Ray DA, Hoffmann FG.

Genome Biol Evol. 2016 Feb 9;8(3):470-80. doi: 10.1093/gbe/evw013.

7.

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA; CHAMPION PHOENIX Investigators.

N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.

8.

Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.

Clay P, Vaught E, Glaros A, Mangum S, Hansen D, Lindsey C.

J Manag Care Pharm. 2007 Jul-Aug;13(6):506-14.

9.

A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients.

Kuppens IE, Witteveen EO, Jewell RC, Radema SA, Paul EM, Mangum SG, Beijnen JH, Voest EE, Schellens JH.

Clin Cancer Res. 2007 Jun 1;13(11):3276-85.

10.

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas.

Burris HA 3rd, Hurwitz HI, Dees EC, Dowlati A, Blackwell KL, O'Neil B, Marcom PK, Ellis MJ, Overmoyer B, Jones SF, Harris JL, Smith DA, Koch KM, Stead A, Mangum S, Spector NL.

J Clin Oncol. 2005 Aug 10;23(23):5305-13. Epub 2005 Jun 13.

PMID:
15955900
11.

Inquiry in baccalaureate nursing education: fostering evidence-based practice.

Callister LC, Matsumura G, Lookinland S, Mangum S, Loucks C.

J Nurs Educ. 2005 Feb;44(2):59-64. Review.

PMID:
15719712
12.

Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies.

Spector NL, Xia W, Burris H 3rd, Hurwitz H, Dees EC, Dowlati A, O'Neil B, Overmoyer B, Marcom PK, Blackwell KL, Smith DA, Koch KM, Stead A, Mangum S, Ellis MJ, Liu L, Man AK, Bremer TM, Harris J, Bacus S.

J Clin Oncol. 2005 Apr 10;23(11):2502-12. Epub 2005 Jan 31.

PMID:
15684311
13.

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.

Bence AK, Anderson EB, Halepota MA, Doukas MA, DeSimone PA, Davis GA, Smith DA, Koch KM, Stead AG, Mangum S, Bowen CJ, Spector NL, Hsieh S, Adams VR.

Invest New Drugs. 2005 Jan;23(1):39-49.

PMID:
15528979
14.

Threading spirituality throughout nursing education.

Callister LC, Bond AE, Matsumura G, Mangum S.

Holist Nurs Pract. 2004 May-Jun;18(3):160-6. Review.

PMID:
15222604
15.

A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care.

Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown SJ, Essary JL, McCandless B.

Diabetes Technol Ther. 2004 Jun;6(3):370-7.

PMID:
15198841
16.

A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.

Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):779-85.

PMID:
14967434
17.

Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects.

Mangum SA, Kraenow KR, Narducci WA.

J Am Pharm Assoc (Wash). 2003 Jan-Feb;43(1):50-5.

PMID:
12585751
18.

Increased efficiency through OR redesign and process simplification.

Mangum SS, Cutler K.

AORN J. 2002 Dec;76(6):1041-6.

PMID:
12528492
19.

Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects.

Mangum SA, Kraenow KR, Narducci WA.

J Am Pharm Assoc (Wash). 2003 Jan;43(1):50-5. doi: 10.1331/10865800360467042.

PMID:
23945804
20.

Comment: Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines.

Manley HJ, Mangum S, Dugan DJ.

Ann Pharmacother. 2002 Dec;36(12):1975-6; author reply 1976. No abstract available.

PMID:
12452768

Supplemental Content

Loading ...
Support Center